Phase 1 clinical trial for assessment of safety of a multi component botanical therapeutic SKBSITA

SK Biolabs1 个研究点分布在 1 个国家目标入组 100 人开始时间: 2002年2月9日最近更新: 2017年11月28日

试验速览

阶段: 1 期
状态: 已完成
发起方
入组人数: 100
试验地点: 1
主要终点: Any toxic side effects after oral administration of SKBSITA such as fever, nausea, vomiting, cramps, headache, stomachache, backache, palpitations, dizziness, paralysis,skin rashes, choking, numbness, anxiety, depression, cough, shortness of breath etc.

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

Multi component botanical therapeutic SKBSITA causes no toxicity in healthy human volunteers.

研究设计

研究类型: Interventional
分配方式: Not Applicable
盲法: Not Applicable

入排标准

年龄范围: 18.00 Year(s) 至 90.00 Year(s)（—）
性别: All

入选标准

•Healthy Human Volunteers.

排除标准

•Patients suffering from any disease.

结局指标

主要结局

Any toxic side effects after oral administration of SKBSITA such as fever, nausea, vomiting, cramps, headache, stomachache, backache, palpitations, dizziness, paralysis,skin rashes, choking, numbness, anxiety, depression, cough, shortness of breath etc.

时间窗: 4 Hours

次要结局

Any toxic side effects after oral administration of SKBSITA such as fever, nausea, vomiting, cramps, headache, stomachache, backache, palpitations, dizziness, paralysis,skin rashes, choking, numbness, anxiety, depression, cough, shortness of breath etc.(15 days)

研究者

发起方

SK Biolabs

申办方类型

Research institution

研究点 (1)

Loading locations...

相似试验

已完成

1 期

A trial to test the safety of a herbal formulation

CTRI/2018/01/011439SK Biolabs100

已完成

1 期

A trial to test the safety of a drug

CTRI/2017/12/010788SK Biolabs100

已完成

1 期

Safety and Pharmacokinetics of Smoked Cannabis in Healthy PatientsHealthy Volunteers

NCT04314804Tetra Bio-Pharma48

已完成

1 期

Single dose study of SK-0348Healthy adult subjects

JPRN-jRCT2071220001Kenji Asano46

招募中

1 期

A Phase I/II trial to determine the Safety, Toxicity and Efficacy of Iodine-131-Rituximab and the Histone Deacetylase Inhibitor Panobinostat in Relapsed and Refractory Indolent B-cell LymphomaRelapsed and Refractory Indolent B-cell LymphomaCancer - Lymphoma (non Hodgkin's lymphoma) - Low grade lymphoma

ACTRN12612000746831Peter MacCallum Cancer Centre30